This page contains our most recent academic publications. If you are looking for our Annual Reports they are here.
– – – – – – – – – – – – – – – – – – – – – – – – – – – – –
Coleman, JJ. “Temporal and external validation of a prediction model for adverse outcomes among inpatients with diabetes.” Diabetic Medicine. 2018 Feb 27. doi: 10.1111/dme.13612. [Epublication ahead of print]
Coleman, JJ. “Impact of a commercial order entry system on prescribing errors amenable to computerised decision support in the hospital setting: a prospective pre-post study.” BMJ Quality & Safety. 2018 Mar 23. doi: 10.1136/bmjqs-2017-007135
Coleman, JJ. “Investigating the ways in which health information technology can promote antimicrobial stewardship: a conceptual overview.” Journal of the Royal Society of Medicine. 2017 Aug; 110(8): 320-329
Anton, Christopher. “Adverse effects of laxatives: update.” Adverse Drug Reaction Bulletin 303, no. 1 (2017): 1171-1174.
Aronson, J. K., and R. E. Ferner. “Unlicensed and off-label uses of medicines: definitions and clarification of terminology.” British journal of clinical pharmacology (2017).
Aronson, Jeffrey K., and Robin E. Ferner. “Biomarkers—a general review.” Current Protocols in Pharmacology (2017): 9-23.
Aronson, Jeffrey K. “Post-marketing drug withdrawals: Pharmacovigilance success, regulatory problems.” Thérapie (2017).
Aronson, Jeffrey K., and Robin E. Ferner. “How similar are biosimilars?.” (2016): i2721.
Badyal, Karamjit, Christopher Anton, and Robin Ferner. “Adverse drug reactions and urological disease.” Trends in Urology & Men’s Health 8.3 (2017): 21-25.
Breckenridge, Alasdair, Jeffrey K. Aronson, Terrence F. Blaschke, Dan Hartman, Carl C. Peck, and Bernard Vrijens. “Poor medication adherence in clinical trials: consequences and solutions.” Nature reviews. Drug discovery 16, no. 3 (2017): 149.
Brooks, Hannah L., Sarah K. Pontefract, Hannah K. Vallance, Christine A. Hirsch, Elizabeth Hughes, Robin E. Ferner, John F. Marriott, and Jamie J. Coleman. “Perceptions and Impact of Mandatory eLearning for Foundation Trainee Doctors: A Qualitative Evaluation.” PloS one 11, no. 12 (2016): e0168558.
Coleman, Jamie J., and Sarah K. Pontefract. “Adverse drug reactions.” Clinical Medicine 16, no. 5 (2016): 481-485.
Ferner, Robin E., Craig Easton, and Anthony R. Cox. “Deaths from Medicines: A Systematic Analysis of Coroners’ Reports to Prevent Future Deaths.” Drug Safety (2017): 1-8.
Ferner, R. E., and J. Aronson. “Medication Errors: Relevance to Pharmacovigilance.” DRUG SAFETY, vol. 39, no. 10, pp. 1030-1030.
Ferner, Robin E., and Jeffrey K. Aronson. “Christmas 2016: In the Literature: Nominal ISOMERs (Incorrect Spellings Of Medicines Eluding Researchers)—variants in the spellings of drug names in PubMed: a database review.” The BMJ 355 (2016).
Ferner, Robin E., and Jeffrey K. Aronson. “The toxicological significance of post-mortem drug concentrations in bile.” Clinical Toxicology (2017): 1-8.
Fox A, Pontefract S, Brown D, Portlock J, Coleman J. Developing consensus on hospital prescribing indicators of potential harm for infants and children. British journal of clinical pharmacology. 2016 Apr 1. doi: 10.1111/bcp.12954
Holland, Michael G., and Robin E. Ferner. “A systematic review of the evidence for acute tolerance to alcohol–the “Mellanby effect”.” Clinical toxicology 55, no. 6 (2017): 545-556.
Maxwell, Simon RJ, Jamie J. Coleman, Lynne Bollington, Celia Taylor, and David J. Webb. “Prescribing Safety Assessment 2016: Delivery of a national prescribing assessment to 7343 UK final‐year medical students.” British Journal of Clinical Pharmacology (2017).
McCullough, Amanda, Anna M. Scott, Christopher Macindoe, Justin Clark, Malene Plejdrup Hansen, Elaine M. Beller, Jeffrey K. Aronson, and Chris B. Del Mar. “Adverse events in patients taking cephalosporins versus placebo for any indication.” The Cochrane Library (2016).
Nirantharakumar, K., N. Adderley, T. Marshall, G. Rayman, S. Mallett, S. Ghosh, F. Akiboye, S. Bellary, K. Toulis, and J. Coleman. “External validation of a prediction model that identifies adverse outcomes in hospitalised patients with diabetes.” In DIABETIC MEDICINE, vol. 34, pp. 6-6. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY, 2017.
O’Donovan B, Rodgers RM, Cox AR and Krska J. Patients’ use of information sources regarding side effects Pharmacoepidemiology and Drug Safety, 2017; 26:15-16 (Prescribing And Research In Medicine Management (Uk & Ireland) Annual Conference 2017, University Of Coventry London Campus, January 28th 2017: “Deprescribing – Is Less More?”)
Onakpoya, Igho J., Carl J. Heneghan, and Jeffrey K. Aronson. “Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.” Pharmacoepidemiology and Drug Safety (2017).
Onakpoya, Igho J., Carl J. Heneghan, and Jeffrey K. Aronson. “Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: an analysis of justification.” Drug safety 40, no. 5 (2017): 431-441.
Onakpoya, Igho J., Carl J. Heneghan, and Jeffrey K. Aronson. “Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.” BMC medicine 14, no. 1 (2016): 191.
Onakpoya, Igho J., Carl J. Heneghan, and Jeffrey K. Aronson. “Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis.” Critical reviews in toxicology 46, no. 6 (2016): 477-489.
Pontefract, Sarah K., James Hodson, John F. Marriott, Sabi Redwood, and Jamie J. Coleman. “Pharmacist-Physician Communications in a Highly Computerised Hospital: Sign-Off and Action of Electronic Review Messages.” PloS one 11, no. 8 (2016): e0160075.
Seidling, Hanna M., Marion Stützle, Torsten Hoppe-Tichy, Benoît Allenet, Pierrick Bedouch, Pascal Bonnabry, Jamie J. Coleman et al. “Best practice strategies to safeguard drug prescribing and drug administration: an anthology of expert views and opinions.” International journal of clinical pharmacy 38, no. 2 (2016): 362-373.
Seidling HM, Stützle M, Hoppe-Tichy T, Allenet B, Bedouch P, Bonnabry P, Coleman JJ, Fernandez-Llimos F, Lovis C, Rei MJ, Störzinger D, Taylor LA, Pontefract SK, van den Bemt PM, van der Sijs H, Haefeli WE. Best practice strategies to safeguard drug prescribing and drug administration: an anthology of expert views and opinions. Int J Clin Pharm 2016 Apr;38(2):362-73.